Cost Effectiveness of Empagliflozin in Patients with T2DM and High CV Risk in Canada
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1882
https://www.valueinhealthjournal.com/article/S1098-3015(16)33248-X/fulltext
Title :
Cost Effectiveness of Empagliflozin in Patients with T2DM and High CV Risk in Canada
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33248-X&doi=10.1016/j.jval.2016.09.1882
First page :
A674
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1782